Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery.

Beffinger M, Schellhammer L, Pantelyushin S, Vom Berg J.

J Vis Exp. 2019 Jul 18;(149). doi: 10.3791/59675.

PMID:
31380848
2.

CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis.

Beffinger M, Tallón de Lara P, Tugues S, Vermeer M, Montagnolo Y, Ohs I, Cecconi V, Lucchiari G, Gagliardi A, Misljencevic N, Sutton J, Spörri R, Becher B, Gupta A, van den Broek M.

JCI Insight. 2018 May 17;3(10). pii: 97792. doi: 10.1172/jci.insight.97792. eCollection 2018 May 17.

3.

Stromal Expression of Activated Leukocyte Cell Adhesion Molecule Promotes Lung Tumor Growth and Metastasis.

Willrodt AH, Beffinger M, Vranova M, Protsyuk D, Schuler K, Jadhav M, Heikenwalder M, van den Broek M, Borsig L, Halin C.

Am J Pathol. 2017 Nov;187(11):2558-2569. doi: 10.1016/j.ajpath.2017.07.008. Epub 2017 Aug 17.

4.

Rational Combination of Immunotherapies with Clinical Efficacy in Mice with Advanced Cancer.

Bransi A, Salgado OC, Beffinger M, Milo K, Silina K, Yagita H, Becher B, Knuth A, van den Broek M.

Cancer Immunol Res. 2015 Nov;3(11):1279-88. doi: 10.1158/2326-6066.CIR-15-0103-T. Epub 2015 Jul 3.

5.

Targeting of FLT3-ITD kinase contributes to high selectivity of imidazoacridinone C-1311 against FLT3-activated leukemia cells.

Skwarska A, Augustin E, Beffinger M, Wojtczyk A, Konicz S, Laskowska K, Polewska J.

Biochem Pharmacol. 2015 Jun 15;95(4):238-52. doi: 10.1016/j.bcp.2015.04.006. Epub 2015 Apr 17.

PMID:
25896848
6.

The role of FLT3 kinase as an AML therapy target.

Beffinger M, Skwarska A.

Curr Pharm Des. 2012;18(19):2758-65. Review.

PMID:
22390761

Supplemental Content

Loading ...
Support Center